SOX2 and central nervous system cancer: Together, those results indicated that suppressing SOX2 and Nestin signaling by the integrin αvβ3 inhibitor efficiently improved the anticancer effects of the conventional chemotherapeutic agent, providing an innovative approach in glioma therapy.